Analysis of Roch Holding AG - wave analysisExpecting fall in share price until 2026 = good moment to buy
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
13.4 CHF
11.50 B CHF
58.72 B CHF
29.02 M
About ROCHE I
Sector
CEO
Thomas Schinecker
Headquarters
Basel
Website
Founded
1896
ISIN
CH0012032113
FIGI
BBG000BCLWW1
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Roche vs. Novo Nordisk: Who will suffer the Weight Loss?Roche (ticker: ROG.SW) is losing ground on the stock due to the side effects of its new weight loss pill, CT-996, which is still in the testing phase. After a rally that boosted its shares 40% between May and September, the Swiss drugmaker has seen an 11% drop in its shares in September alone, inclu
Roche Analysis 6/26DISCLOSURE: as of 6/26 I have no open position in SIX:RO
Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment.
Management Effectiveness: Roche has been around since 1896
Roche: Ready for 120% Growth?We're trying something with Roche here, where we think that we are currently in Wave (5), having recently completed Wave (4). This assessment is better visualized on the daily chart. Hence, we should maintain the 61.8% level for this Wave 4. Anything below would statistically be too low, while above
Hold it like a rock - Roche, what an opportunity.Hi, 1PERCENT here.
Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma.
There were only 3 pull backs greater than 30% in the history of the stock.
2002 ~ 2003: -45.33%
2006 ~ 2011: -52.40%
2014 ~ 2018: -30.24%
2022 ~ present: -44.89%
It is at the support z
ROG corrective rally to come?ROG has experienced a 5 wave decline visible on the weekly timeframe. We can now expect at least a 3 wave corrective rally that can potentially reach the golden pocket at $332
Roche HoldingsThis is one of those companies you can't afford not to look into. Roche is one of the world's largest biotech companies and a global leader in pharmaceuticals and diagnostics. This leading position translates to strong market share, revenue, and profitability. The company operates across various seg
Long Term Weekly Trend holds for nowTrend started in 2012 held during the week. If the price accumulates at the current level and we breakout to the upside, I will watch the marked zones of interest and see how the price reacts.
If we breakout to the down side, I will look for interesting price levels and keep an eye on the trend est
Roche Holding AG (ROG.SW) Stock Hello ladies and gentlemen,
according to my stock chart analysis, there is a high probability of a decline toward the $303.50 level in the next few days!
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where RO is featured.
Frequently Asked Questions
The current price of RO is 269.8 CHF — it has increased by 0.37% in the past 24 hours. Watch ROCHE I stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange ROCHE I stocks are traded under the ticker RO.
RO stock has risen by 3.07% compared to the previous week, the month change is a −0.30% fall, over the last year ROCHE I has showed a 4.17% increase.
We've gathered analysts' opinions on ROCHE I future price: according to them, RO price has a max estimate of 440.00 CHF and a min estimate of 230.00 CHF. Watch RO chart and read a more detailed ROCHE I stock forecast: see what analysts think of ROCHE I and suggest that you do with its stocks.
RO stock is 1.05% volatile and has beta coefficient of 1.13. Track ROCHE I stock price on the chart and check out the list of the most volatile stocks — is ROCHE I there?
Today ROCHE I has the market capitalization of 213.22 B, it has decreased by −2.70% over the last week.
Yes, you can track ROCHE I financials in yearly and quarterly reports right on TradingView.
ROCHE I is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
RO earnings for the last half-year are 10.23 CHF per share, whereas the estimation was 9.37 CHF, resulting in a 9.24% surprise. The estimated earnings for the next half-year are 8.39 CHF per share. See more details about ROCHE I earnings.
ROCHE I revenue for the last half-year amounts to 30.76 B CHF, despite the estimated figure of 29.61 B CHF. In the next half-year revenue is expected to reach 30.62 B CHF.
RO net income for the last half-year is 6.26 B CHF, while the previous report showed 4.36 B CHF of net income which accounts for 43.50% change. Track more ROCHE I financial stats to get the full picture.
Yes, RO dividends are paid annually. The last dividend per share was 9.60 CHF. As of today, Dividend Yield (TTM)% is 3.59%. Tracking ROCHE I dividends might help you take more informed decisions.
ROCHE I dividend yield was 3.67% in 2023, and payout ratio reached 66.71%. The year before the numbers were 2.65% and 61.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 103.61 K employees. See our rating of the largest employees — is ROCHE I on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE I EBITDA is 19.84 B CHF, and current EBITDA margin is 33.76%. See more stats in ROCHE I financial statements.
Like other stocks, RO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE I stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROCHE I technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROCHE I stock shows the sell signal. See more of ROCHE I technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.